SOVERINI, SIMONA
SOVERINI, SIMONA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Simona Soverini; SOVERINI S.; Soverini Simona; S. SOVERINI
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis
2024 Sciumè, Mariarita; Serpenti, Fabio; Zanotti, Roberta; Bonadonna, Patrizia; Tanasi, Ilaria; Crosera, Lara; Elena, Chiara; Mannelli, Francesco; Crupi, Francesca; Papayannidis, Cristina; Sartor, Chiara; Soverini, Simona; Rondoni, Michela; Eller‐Vainicher, Cristina; Pravettoni, Valerio; Rivolta, Federica; Alberti Violetti, Silvia; Croci, Giorgio Alberto; Migliorini, Anna Chiara; Bolli, Niccolò; Giannarelli, Diana; Grifoni, Federica Irene
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia
2023 Cross N.C.P.; Ernst T.; Branford S.; Cayuela J.-M.; Deininger M.; Fabarius A.; Kim D.D.H.; Machova Polakova K.; Radich J.P.; Hehlmann R.; Hochhaus A.; Apperley J.F.; Soverini S.
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights
2023 Iezza M.; Cortesi S.; Ottaviani E.; Mancini M.; Venturi C.; Monaldi C.; De Santis S.; Testoni N.; Soverini S.; Rosti G.; Cavo M.; Castagnetti F.
Resistance mutations in CML and how we approach them
2023 Soverini S.
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted
2023 Mancini M.; Monaldi C.; De Santis S.; Papayannidis C.; Rondoni M.; Sartor C.; Bruno S.; Pagano L.; Criscuolo M.; Zanotti R.; Bonifacio M.; Tosi P.; Arock M.; Valent P.; Cavo M.; Soverini S.
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
2022 Bruno S.; Ghelli Luserna di Rora A.; Napolitano R.; Soverini S.; Martinelli G.; Simonetti G.
CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors
2022 de Santis S.; Monaldi C.; Martelli M.; Mancini M.; Bruno S.; Castagnetti F.; Gugliotta G.; Polakova K.M.; Ernst T.; Maar D.; Corner A.; Cavo M.; Soverini S.
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells
2022 Mancini M.; Monaldi C.; De Santis S.; Rondoni M.; Papayannidis C.; Sartor C.; Curti A.; Bruno S.; Cavo M.; Soverini S.
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia
2022 Soverini S.; De Santis S.; Martelli M.; Monaldi C.; Castagnetti F.; Gugliotta G.; Papayannidis C.; Mancini M.; Bruno S.; Venturi C.; Machova Polakova K.; Ernst T.; Maar D.; Corner A.; Cavo M.
MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis
2022 Monaldi C.; de Santis S.; Mancini M.; Papayannidis C.; Sartor C.; Rondoni M.; Bruno S.; Cavo M.; Soverini S.
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia
2022 De Santis S.; Monaldi C.; Mancini M.; Bruno S.; Cavo M.; Soverini S.
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors
2022 Mancini M.; De Santis S.; Monaldi C.; Castagnetti F.; Lonetti A.; Bruno S.; Dan E.; Sinigaglia B.; Rosti G.; Cavo M.; Gugliotta G.; Soverini S.
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia
2022 Baccarani M.; Bonifazi F.; Soverini S.; Castagnetti F.; Gugliotta G.; Saber W.; Estrada-Merly N.; Rosti G.; Gale R.P.
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study
2022 Gugliotta G.; Castagnetti F.; Breccia M.; Levato L.; Intermesoli T.; D'Adda M.; Salvucci M.; Stagno F.; Rege-Cambrin G.; Tiribelli M.; Martino B.; Bocchia M.; Cedrone M.; Trabacchi E.; Cavazzini F.; Porretto F.; Sora F.; Simula M.P.; Albano F.; Soverini S.; Foa R.; Pane F.; Cavo M.; Saglio G.; Baccarani M.; Rosti G.
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network
2021 Schafer V.; White H.E.; Gerrard G.; Mobius S.; Saussele S.; Franke G.-N.; Mahon F.-X.; Talmaci R.; Colomer D.; Soverini S.; Machova Polakova K.; Cross N.C.P.; Hochhaus A.; Ernst T.
BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGS
2021 Soverini S.; Martelli M.; Bavaro L.; De Benedittis C.; Sica S.; Sora F.; Iurlo A.; Bonifacio M.; Pregno P.; Galimberti S.; Lunghi F.; Albano F.; D'Adda M.; Crugnola M.; Capodanno I.; Castagnetti F.; Gugliotta G.; Papayannidis C.; Rosti G.; Percesepe A.; Mignone F.; Baccarani M.; Martinelli G.; Cavo M.
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia
2021 Bruno S.; Bandini L.; Patuelli A.; Robustelli V.; Venturi C.; Mancini M.; Forte D.; De Santis S.; Monaldi C.; Grassi A.; Chiurumbolo G.; Paolini S.; Cristiano G.; Papayannidis C.; Sartor C.; Nanni J.; Ottaviani E.; Curti A.; Cavo M.; Soverini S.
Improving prognostication and management of systemic mastocytosis
2021 Soverini S.
INCB84344-201: Ponatinib and steroids in frontline therapy of unfit patients with Ph+ acute lymphoblastic leukemia
2021 Martinelli, Giovanni; Papayannidis, Cristina; Piciocchi, Alfonso; Robustelli, Valentina; Soverini, Simona; Terragna, Carolina; Marconi, Giovanni; Lemoli, Roberto Massimo; Guolo, Fabio; Fornaro, Antonella; Lunghi, Monia; de Fabritiis, Paolo; Candoni, Anna; Selleri, Carmine; Simonetti, Federico; Bocchia, Monica; Vitale, Antonella; Frison, Luca; Tedeschi, Alessandra; Cuneo, Antonio; Bonifacio, Massimiliano; Martelli, Maria Paola; D'Ardia, Stefano; Trappolini, Silvia; Tosi, Patrizia; Galieni, Piero; Fabbiano, Francesco; Abbenante, Maria Chiara; Granier, Muriel; Zhu, Zhaoyin; Wang, Mingyue; Sartor, Chiara; Paolini, Stefania; Cavo, Michele; Foà, Robin; Fazi, Paola; Vignetti, Marco; Baccarani, Michele
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant
2021 Papayannidis C.; Sartor C.; Dominietto A.; Zappone E.; Arpinati M.; Marconi G.; Cristiano G.; Nanni J.; Parisi S.; Barbato F.; Paolini S.; Soverini S.; Terragna C.; Robustelli V.; Testoni N.; Chirumbolo G.; Curti A.; Cavo M.; Bonifazi F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis | Sciumè, Mariarita; Serpenti, Fabio; Zanotti, Roberta; Bonadonna, Patrizia; Tanasi, Ilaria; Croser...a, Lara; Elena, Chiara; Mannelli, Francesco; Crupi, Francesca; Papayannidis, Cristina; Sartor, Chiara; Soverini, Simona; Rondoni, Michela; Eller‐Vainicher, Cristina; Pravettoni, Valerio; Rivolta, Federica; Alberti Violetti, Silvia; Croci, Giorgio Alberto; Migliorini, Anna Chiara; Bolli, Niccolò; Giannarelli, Diana; Grifoni, Federica Irene | 2024-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia | Cross N.C.P.; Ernst T.; Branford S.; Cayuela J.-M.; Deininger M.; Fabarius A.; Kim D.D.H.; Machov...a Polakova K.; Radich J.P.; Hehlmann R.; Hochhaus A.; Apperley J.F.; Soverini S. | 2023-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | s41375-023-02048-y-4.pdf |
| Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights | Iezza M.; Cortesi S.; Ottaviani E.; Mancini M.; Venturi C.; Monaldi C.; De Santis S.; Testoni N.;... Soverini S.; Rosti G.; Cavo M.; Castagnetti F. | 2023-01-01 | CELLS | - | 1.01 Articolo in rivista | cells-12-01703-v2.pdf |
| Resistance mutations in CML and how we approach them | Soverini S. | 2023-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted | Mancini M.; Monaldi C.; De Santis S.; Papayannidis C.; Rondoni M.; Sartor C.; Bruno S.; Pagano L....; Criscuolo M.; Zanotti R.; Bonifacio M.; Tosi P.; Arock M.; Valent P.; Cavo M.; Soverini S. | 2023-01-01 | BIOMARKER RESEARCH | - | 1.01 Articolo in rivista | Mancini_2023.pdf; 40364_2023_468_MOESM1_ESM.docx |
| CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies | Bruno S.; Ghelli Luserna di Rora A.; Napolitano R.; Soverini S.; Martinelli G.; Simonetti G. | 2022-01-01 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | Bruno_JECCR_2022.pdf; 13046_2022_2363_MOESM1_ESM.docx |
| CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors | de Santis S.; Monaldi C.; Martelli M.; Mancini M.; Bruno S.; Castagnetti F.; Gugliotta G.; Polako...va K.M.; Ernst T.; Maar D.; Corner A.; Cavo M.; Soverini S. | 2022-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells | Mancini M.; Monaldi C.; De Santis S.; Rondoni M.; Papayannidis C.; Sartor C.; Curti A.; Bruno S.;... Cavo M.; Soverini S. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-00738.pdf; cancers-14-00738-s001.zip |
| Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia | Soverini S.; De Santis S.; Martelli M.; Monaldi C.; Castagnetti F.; Gugliotta G.; Papayannidis C....; Mancini M.; Bruno S.; Venturi C.; Machova Polakova K.; Ernst T.; Maar D.; Corner A.; Cavo M. | 2022-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis | Monaldi C.; de Santis S.; Mancini M.; Papayannidis C.; Sartor C.; Rondoni M.; Bruno S.; Cavo M.; ...Soverini S. | 2022-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia | De Santis S.; Monaldi C.; Mancini M.; Bruno S.; Cavo M.; Soverini S. | 2022-01-01 | ONCOTARGETS AND THERAPY | - | 1.01 Articolo in rivista | OTT-289306-overcoming-resistance-to-kinase-inhibitors--the-paradigm-of-.pdf |
| Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors | Mancini M.; De Santis S.; Monaldi C.; Castagnetti F.; Lonetti A.; Bruno S.; Dan E.; Sinigaglia B....; Rosti G.; Cavo M.; Gugliotta G.; Soverini S. | 2022-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-12-901132.pdf; file supplementari.zip |
| Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia | Baccarani M.; Bonifazi F.; Soverini S.; Castagnetti F.; Gugliotta G.; Saber W.; Estrada-Merly N.;... Rosti G.; Gale R.P. | 2022-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | Baccarani_Leukemia_2022.pdf |
| Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study | Gugliotta G.; Castagnetti F.; Breccia M.; Levato L.; Intermesoli T.; D'Adda M.; Salvucci M.; Stag...no F.; Rege-Cambrin G.; Tiribelli M.; Martino B.; Bocchia M.; Cedrone M.; Trabacchi E.; Cavazzini F.; Porretto F.; Sora F.; Simula M.P.; Albano F.; Soverini S.; Foa R.; Pane F.; Cavo M.; Saglio G.; Baccarani M.; Rosti G. | 2022-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | 10596-Article Text-77970-2-10-20220928.pdf; 2021_280175_GUGLIOTTA_SUPPL.pdf |
| Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network | Schafer V.; White H.E.; Gerrard G.; Mobius S.; Saussele S.; Franke G.-N.; Mahon F.-X.; Talmaci R....; Colomer D.; Soverini S.; Machova Polakova K.; Cross N.C.P.; Hochhaus A.; Ernst T. | 2021-01-01 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | Schäfer2021_Article_AssessmentOfIndividualMolecula(1).pdf; 432_2021_3569_MOESM1_ESM.pdf |
| BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGS | Soverini S.; Martelli M.; Bavaro L.; De Benedittis C.; Sica S.; Sora F.; Iurlo A.; Bonifacio M.; ...Pregno P.; Galimberti S.; Lunghi F.; Albano F.; D'Adda M.; Crugnola M.; Capodanno I.; Castagnetti F.; Gugliotta G.; Papayannidis C.; Rosti G.; Percesepe A.; Mignone F.; Baccarani M.; Martinelli G.; Cavo M. | 2021-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia | Bruno S.; Bandini L.; Patuelli A.; Robustelli V.; Venturi C.; Mancini M.; Forte D.; De Santis S.;... Monaldi C.; Grassi A.; Chiurumbolo G.; Paolini S.; Cristiano G.; Papayannidis C.; Sartor C.; Nanni J.; Ottaviani E.; Curti A.; Cavo M.; Soverini S. | 2021-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-11-728613.pdf |
| Improving prognostication and management of systemic mastocytosis | Soverini S. | 2021-01-01 | THE LANCET. HAEMATOLOGY | - | 1.03 Recensione in rivista | - |
| INCB84344-201: Ponatinib and steroids in frontline therapy of unfit patients with Ph+ acute lymphoblastic leukemia | Martinelli, Giovanni; Papayannidis, Cristina; Piciocchi, Alfonso; Robustelli, Valentina; Soverini..., Simona; Terragna, Carolina; Marconi, Giovanni; Lemoli, Roberto Massimo; Guolo, Fabio; Fornaro, Antonella; Lunghi, Monia; de Fabritiis, Paolo; Candoni, Anna; Selleri, Carmine; Simonetti, Federico; Bocchia, Monica; Vitale, Antonella; Frison, Luca; Tedeschi, Alessandra; Cuneo, Antonio; Bonifacio, Massimiliano; Martelli, Maria Paola; D'Ardia, Stefano; Trappolini, Silvia; Tosi, Patrizia; Galieni, Piero; Fabbiano, Francesco; Abbenante, Maria Chiara; Granier, Muriel; Zhu, Zhaoyin; Wang, Mingyue; Sartor, Chiara; Paolini, Stefania; Cavo, Michele; Foà, Robin; Fazi, Paola; Vignetti, Marco; Baccarani, Michele | 2021-01-01 | BLOOD ADVANCES | - | 1.01 Articolo in rivista | Martinelli_Blood Adv 2022.pdf |
| Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant | Papayannidis C.; Sartor C.; Dominietto A.; Zappone E.; Arpinati M.; Marconi G.; Cristiano G.; Nan...ni J.; Parisi S.; Barbato F.; Paolini S.; Soverini S.; Terragna C.; Robustelli V.; Testoni N.; Chirumbolo G.; Curti A.; Cavo M.; Bonifazi F. | 2021-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |